IFPAC brings together experienced professionals and the next generation of leaders to share in discussions, give input and get ideas for the future well-being of the industry. This year at the event, Germfree’s Chief Strategy Officer, Carol Houts, will discuss how decentralized manufacturing models are starting to challenge the established norms by offering a novel perspective on therapy delivery.

The panel includes several speakers from the FDA, EMA, MHRA, and companies like OnDemand Pharma, and Orgenesis. This session, held on Tuesday, March 5th, from 7:50 AM – 12:00 PM, is broadly focused upon portable, distributed, and point-of-care manufacturing. This includes regulatory considerations, pod manufacturing with portability to the manufacturing unit, and manufacturing directly to the patient.

Don’t miss out on this opportunity to dive deep into the world of decentralized/point-of-care manufacturing!